Stock analysis searches answered, part 39 of 43

Farmmi farmmi inc farmmi.com.cn

Also searched as: "farmmi" | "farmmi inc" | "farmmi.com.cn"

This section ties “Farmmi farmmi inc farmmi.com.cn” to Farmmi, Inc. (ticker FAMI), SEC Central Index Key 1701261, an EDGAR registrant classified as “Canned, Fruits, Veg, Preserves, Jams & Jellies” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-08-27. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-02-10 by Farmmi, Inc. (CIK 1701261) — source document:

Farmmi, Inc. (“FAMI”), is a Cayman Islands holding company incorporated on July 28, 2015. We conduct our operations in China principally through our foreign-owned PRC subsidiaries. FAMI’s registered office is at the office of Sertus Incorporations (Cayman) Limited, Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands. Its registered office’s telephone number is +1.345.745.5100. Farmmi, Inc.’s agent in the U.S. is Shangzhi Zhang, with the address of 33202 Havers Drive, Cary, NC 27518. FLS Mushroom, a major operating entity of our Company prior to its divestiture in September 2022, previously was under mushroom business sectors of Forasen Group, which is controlled by Ms.

Financial trend for Farmmi, Inc. from annual reports, periods 2022-09-30 to 2025-09-30: revenue went from $99.21 million (2022-09-30) to $27.97 million (2025-09-30), a change of -71.8%; net income (loss) went from $2.22 million (2022-09-30) to -$53.10 million (2025-09-30), a change of -2487.6%; total assets went from $163.78 million (2022-09-30) to $147.03 million (2025-09-30), a change of -10.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1701261, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Farmmi, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Farmmi, Inc. (CIK 1701261) lists its business address as FL 1, BUILDING NO. 1, LISHUI, ZHEJIANG PROVINCE, China, which helps confirm you are on the right company’s site.

Current reports. Of the 106 8-K or 6-K reports in Farmmi, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-22 to 2026-08-27, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1701261 is on the EDGAR company page; the latest 20-F there is dated 2026-02-10 and the oldest filing in the recent index dates from 2017-05-05. Insider trades for Farmmi, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Frontview reit frontview reit inc. frontviewreit.com

Also searched as: "frontview reit" | "frontview reit inc." | "frontviewreit.com"

This section ties “Frontview reit frontview reit inc. frontviewreit.com” to FrontView REIT, Inc. (ticker FVR), SEC Central Index Key 1988494, an EDGAR registrant classified as “Real Estate Investment Trusts” and organised in MD. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-19. Nothing here is a recommendation to trade the security.

Financial trend for FrontView REIT, Inc. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $48.27 million (2023-12-31) to $67.11 million (2025-12-31), a change of +39.1%; net income (loss) went from -$1.10 million (2023-12-31) to -$3.83 million (2025-12-31), a change of -248.1%; total assets went from $772.01 million (2023-12-31) to $854.44 million (2025-12-31), a change of +10.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1988494, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures FrontView REIT, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for FrontView REIT, Inc. (CIK 1988494) lists its business address as 3131 MCKINNEY AVENUE, DALLAS, TX, which helps confirm you are on the right company’s site.

Current reports. Of the 37 8-K or 6-K reports in FrontView REIT, Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-14 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 213 recent EDGAR filings, FrontView REIT, Inc. most often filed 4 (70), 8-K (37), SCHEDULE 13G/A (15), 3 (15). A selection from 2026-09-16 to 2026-10-16:

The full record for CIK 1988494 is on the EDGAR company page; the latest 10-K there is dated 2026-02-25 and the oldest filing in the recent index dates from 2023-08-23. Insider trades for FrontView REIT, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Genelux genelux corporation genelux corp genelux.com

Also searched as: "genelux" | "genelux corporation" | "genelux corp" | "genelux.com"

This section ties “Genelux genelux corporation genelux corp genelux.com” to GENELUX Corp (ticker GNLX), SEC Central Index Key 1231457, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-09-02. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-19 by GENELUX Corp (CIK 1231457) — source document:

Genelux is a late clinical-stage biopharmaceutical company focused on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat tumor types. Our clinical and preclinical product candidates are intended to selectively kill tumor cells and induce a robust immune response against a patient’s tumor neoantigens. Importantly, our oncolytic immunotherapy product candidates are “off-the-shelf” personalized immunotherapies. In other words, while we administer the same virus product to different patients, the cellular immune response generated is expected to be specific to the unique neoantigens in that patient. Our lead product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus (VACV), a stable DNA virus with a large engineering capacity.

Financial trend for GENELUX Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $11.07 million (2022-12-31) to $8,000 (2025-12-31), a change of -99.9%; net income (loss) went from -$5.21 million (2022-12-31) to -$32.15 million (2025-12-31), a change of -517.3%; total assets went from $5.53 million (2022-12-31) to $19.03 million (2025-12-31), a change of +244.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1231457, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures GENELUX Corp did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for GENELUX Corp (CIK 1231457) lists its business address as 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 31 8-K or 6-K reports in GENELUX Corp’s recent EDGAR index, the 4 listed here run from 2026-01-08 to 2026-06-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1231457 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2003-05-05. Insider trades for GENELUX Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Globa terra acquisition

Also searched as: "globa terra acquisition"

This section ties “Globa terra acquisition” to Globa Terra Acquisition Corp (ticker GTERA, GTERR, GTERU, GTERW), SEC Central Index Key 2043766, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-22. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-26 by Globa Terra Acquisition Corp (CIK 2043766) — source document:

We are a newly organized blank check company incorporated as a Cayman Islands exempted company on October 18, 2024 for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report as our initial business combination. We have not commenced any operations nor generated any revenues to date. All activity for the period from October 18, 2024 (inception) through December 31, 2025 relates to our formation and the Initial Public Offering, and since the Initial Public Offering to our search for an initial business combination. We are also an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.

Financial trend for Globa Terra Acquisition Corp from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) was tagged only for 2025-12-31 at $2.88 million; total assets went from $577,682 (2024-12-31) to $179.07 million (2025-12-31), a change of +30898.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2043766, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Globa Terra Acquisition Corp did not tag for that period.

Deal and listing documents for Globa Terra Acquisition Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 5 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2025-07-09.

Current reports. Of the 4 8-K or 6-K reports in Globa Terra Acquisition Corp’s recent EDGAR index, the 4 listed here run from 2025-07-10 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2043766 is on the EDGAR company page; the latest 10-K there is dated 2026-03-26 and the oldest filing in the recent index dates from 2024-11-26. Insider trades for Globa Terra Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Green circle decarbonize pcmtes.com

Also searched as: "green circle decarbonize" | "pcmtes.com"

This section ties “Green circle decarbonize pcmtes.com” to Green Circle Decarbonize Technology Ltd (ticker GCDT), SEC Central Index Key 1926293, an EDGAR registrant classified as “Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-21. Nothing here is a recommendation to trade the security.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Green Circle Decarbonize Technology Ltd (CIK 1926293) lists its business address as FLAT 1809, PROSPERITY PLACE, HONG KONG, Hong Kong, which helps confirm you are on the right company’s site.

Current reports. Of the 20 8-K or 6-K reports in Green Circle Decarbonize Technology Ltd’s recent EDGAR index, the 4 listed here run from 2026-10-06 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 68 recent EDGAR filings, Green Circle Decarbonize Technology Ltd most often filed 6-K (20), F-1/A (14), 3 (7), DRS/A (7). A selection from 2026-08-31 to 2026-10-14:

The full record for CIK 1926293 is on the EDGAR company page; the latest 20-F there is dated 2026-08-14 and the oldest filing in the recent index dates from 2022-05-26. Insider trades for Green Circle Decarbonize Technology Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Haoxi health technology ltd haoxi health technology

Also searched as: "haoxi health technology ltd" | "haoxi health technology"

This section ties “Haoxi health technology ltd haoxi health technology” to Haoxi Health Technology Ltd (ticker HAO), SEC Central Index Key 1954594, an EDGAR registrant classified as “Services-Advertising Agencies” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 20-F dated 2026-09-30. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-09-30 by Haoxi Health Technology Ltd (CIK 1954594) — source document:

Haoxi Beijing is a limited liability company incorporated on September 26, 2018 under the laws of China. It was formerly known as Beijing Haoxi Culture Media Co., Ltd. On September 4, 2020, Haoxi Beijing changed its name to Beijing Haoxi Digital Technology Co., Ltd. In connection with the IPO, we undertook a reorganization of our corporate structure (the “Reorganization”) in the following steps: ● on August 5, 2022, Haoxi Cayman was incorporated as an exempted company limited by shares in the Cayman Islands; ● on August 30, 2022, Haoxi Cayman incorporated its wholly owned subsidiary, Haoxi HK, in Hong Kong; ● on October 13, 2022, Haoxi HK incorporated its wholly owned subsidiary, WFOE, in the PRC; and ● on November 25, 2022, WFOE acquired 100% equity interest of Haoxi Beijing.

Financial trend for Haoxi Health Technology Ltd from annual reports, periods 2023-06-30 to 2026-06-30: revenue went from $28.23 million (2023-06-30) to $54.83 million (2026-06-30), a change of +94.2%; net income (loss) went from $969,752 (2023-06-30) to -$9.54 million (2026-06-30), a change of -1083.4%; total assets went from $4.46 million (2023-06-30) to $21.57 million (2026-06-30), a change of +383.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1954594, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Haoxi Health Technology Ltd did not tag for that period.

Haoxi Health Technology Ltd has 105 filings in its recent EDGAR index, including 3 annual reports and 0 quarterly reports; its newest filing is a 20-F from 2026-09-30.

Current reports. Of the 30 8-K or 6-K reports in Haoxi Health Technology Ltd’s recent EDGAR index, the 4 listed here run from 2026-06-04 to 2026-07-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1954594 is on the EDGAR company page; the latest 20-F there is dated 2026-09-30 and the oldest filing in the recent index dates from 2023-02-15. Insider trades for Haoxi Health Technology Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Intelligent bio solutions intelligent bio solutions inc. ibs.inc

Also searched as: "intelligent bio solutions" | "intelligent bio solutions inc." | "ibs.inc"

This section ties “Intelligent bio solutions intelligent bio solutions inc. ibs.inc” to INTELLIGENT BIO SOLUTIONS INC. (ticker INBS), SEC Central Index Key 1725430, an EDGAR registrant classified as “Surgical & Medical Instruments & Apparatus” and organised in DE, formerly known as GBS Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a PRE 14A dated 2026-10-23. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-08-19 by INTELLIGENT BIO SOLUTIONS INC. (CIK 1725430) — source document:

Intelligent Bio Solutions Inc. and its wholly owned Delaware subsidiary, GBS Operations Inc., were each formed on December 5, 2016, under the laws of the state of Delaware. The Company’s Australian subsidiary, Intelligent Bio Solutions (APAC) Pty Ltd, was formed on August 4, 2016, under the laws of New South Wales, Australia. On October 4, 2022, INBS acquired Intelligent Fingerprinting Limited (“IFP”), a company registered in England and Wales. Our headquarters are in New York City. Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. The Company operates globally with the objective of providing innovative and accessible solutions that improve the quality of life.

Financial trend for INTELLIGENT BIO SOLUTIONS INC. from annual reports, periods 2023-06-30 to 2026-06-30: net income (loss) went from -$10.63 million (2023-06-30) to -$12.43 million (2026-06-30), a change of -16.9%; total assets went from $10.35 million (2023-06-30) to $11.94 million (2026-06-30), a change of +15.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1725430, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures INTELLIGENT BIO SOLUTIONS INC. did not tag for that period.

INTELLIGENT BIO SOLUTIONS INC. has 465 filings in its recent EDGAR index, including 6 annual reports and 17 quarterly reports; its newest filing is a PRE 14A from 2026-10-23.

Current reports. Of the 167 8-K or 6-K reports in INTELLIGENT BIO SOLUTIONS INC.’s recent EDGAR index, the 4 listed here run from 2026-09-02 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1725430 is on the EDGAR company page; the latest 10-K/A there is dated 2026-10-21 and the oldest filing in the recent index dates from 2017-12-29. Insider trades for INTELLIGENT BIO SOLUTIONS INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Iron dome acquisition i iron dome acquisition i corp. irondome1.com

Also searched as: "iron dome acquisition i" | "iron dome acquisition i corp." | "irondome1.com"

This section ties “Iron dome acquisition i iron dome acquisition i corp. irondome1.com” to Iron Dome Acquisition I Corp. (ticker IDAC, IDACU, IDACW), SEC Central Index Key 2090441, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G dated 2026-08-14. Nothing here is a recommendation to trade the security.

Deal and listing documents for Iron Dome Acquisition I Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 4 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-05-15.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Iron Dome Acquisition I Corp. (CIK 2090441) lists its business address as 244 FIFTH AVENUE, NEW YORK, NY, which helps confirm you are on the right company’s site.

Current reports. Of the 3 8-K or 6-K reports in Iron Dome Acquisition I Corp.’s recent EDGAR index, the 3 listed here run from 2026-05-18 to 2026-07-02, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 22 recent EDGAR filings, Iron Dome Acquisition I Corp. most often filed 3 (5), SCHEDULE 13G (3), 8-K (3), 10-Q (2). A selection from 2026-06-26 to 2026-08-14:

The full record for CIK 2090441 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-10-22. Insider trades for Iron Dome Acquisition I Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Je cleantech je cleantech holdings limited jecleantech.sg

Also searched as: "je cleantech" | "je cleantech holdings limited" | "jecleantech.sg"

This section ties “Je cleantech je cleantech holdings limited jecleantech.sg” to JE Cleantech Holdings Ltd (ticker JCSE), SEC Central Index Key 1905511, an EDGAR registrant classified as “Miscellaneous Manufacturing Industries” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-20. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-05-08 by JE Cleantech Holdings Ltd (CIK 1905511) — source document:

New Orders On March 30, 2026, we announced that, in the first quarter of 2026, our wholly-owned subsidiary, JCS, secured new orders totaling approximately US$12 million for precision cleaning systems from an existing customer. Barring any unforeseen circumstances, deliveries are expected to be carried out progressively over the next 12 months. 20 Purchase of Motor Vehicle On March 23, 2026, the members of the Board of Directors received an offer from our Chief Executive Officer, Ms. Hong Bee Yin, to sell her motor vehicle, a 2024 BMW 520i Mild Hybrid M-Sport, SCH3663P, (the “Motor Vehicle”) to JCS for a purchase price of S$285,000, and for the Company to subsequently provide the Motor Vehicle to Ms.

Financial trend for JE Cleantech Holdings Ltd from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from 1,192,000 SGD (2022-12-31) to 3,236,000 SGD (2025-12-31), a change of +171.5%; total assets went from 35,465,000 SGD (2022-12-31) to 32,984,000 SGD (2025-12-31), a change of -7.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1905511, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures JE Cleantech Holdings Ltd did not tag for that period.

JE Cleantech Holdings Ltd has 81 filings in its recent EDGAR index, including 5 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-20.

Current reports. Of the 29 8-K or 6-K reports in JE Cleantech Holdings Ltd’s recent EDGAR index, the 4 listed here run from 2026-03-30 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1905511 is on the EDGAR company page; the latest 20-F there is dated 2026-05-08 and the oldest filing in the recent index dates from 2022-01-21. Insider trades for JE Cleantech Holdings Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jupiter neurosciences jupiter neurosciences inc. jupiterneurosciences.com

Also searched as: "jupiter neurosciences" | "jupiter neurosciences inc." | "jupiterneurosciences.com"

This section ties “Jupiter neurosciences jupiter neurosciences inc. jupiterneurosciences.com” to JUPITER NEUROSCIENCES, INC. (ticker JUNS), SEC Central Index Key 1679628, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as Jupiter Orphan Therapeutics, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a S-8 dated 2026-10-13, and this view starts from filings dated on or before 2026-08-24. Nothing here is a recommendation to trade the security.

Financial trend for JUPITER NEUROSCIENCES, INC. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $18,652 (2026-03-31) to $24,245 (2026-06-30), a change of +30.0%; net income (loss) went from -$2.29 million (2025-09-30) to -$2.27 million (2026-06-30), a change of +0.6%; total assets went from $2.58 million (2025-09-30) to $3.72 million (2026-06-30), a change of +44.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1679628, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures JUPITER NEUROSCIENCES, INC. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for JUPITER NEUROSCIENCES, INC. (CIK 1679628) lists its business address as 1001 NORTH US HWY 1, JUPITER, FL, which helps confirm you are on the right company’s site.

Current reports. Of the 27 8-K or 6-K reports in JUPITER NEUROSCIENCES, INC.’s recent EDGAR index, the 4 listed here run from 2026-07-27 to 2026-08-24, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 202 recent EDGAR filings, JUPITER NEUROSCIENCES, INC. most often filed CORRESP (40), 8-K (27), 4 (24), S-1/A (22). A selection from 2026-07-29 to 2026-08-28:

The full record for CIK 1679628 is on the EDGAR company page; the latest 10-K there is dated 2026-04-01 and the oldest filing in the recent index dates from 2016-07-15. One example from this record is the 8-K filed 2026-09-03 (document). Insider trades for JUPITER NEUROSCIENCES, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Krakacquisition krakacquisition corp.

Also searched as: "krakacquisition" | "krakacquisition corp."

This section ties “Krakacquisition krakacquisition corp.” to KRAKacquisition Corp (ticker KRAQ, KRAQU, KRAQW), SEC Central Index Key 2082119, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-08-14, and this view starts from filings dated on or before 2026-01-27. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-30 by KRAKacquisition Corp (CIK 2082119) (passage 3, continuing from the earlier excerpt) — source document:

Based on our business activities, the Company is a “shell company,” as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), because we have no operations and nominal assets consisting almost entirely of cash. Our Sponsor was formed through the partnership of Payward, Inc. (d/b/a Kraken) (“Kraken”), one of the world’s most established global crypto platforms, Tribe Capital, a leading and data-driven venture firm in innovative fintech and crypto markets, and Natural Capital, an investment platform founded by experienced operators with venture capital, public markets and special purpose acquisition company (‘‘SPAC’’) expertise, for the purpose of investing in us. On January 29, 2026, we consummated our Initial Public Offering of 34,500,000 units, which included the full exercise by the underwriters of the over-allotment option to purchase an additional 4,500,000 units, at $10.00 per unit, generating gross proceeds of $345,000,000 (the “Initial Public Offering”).

Other filings. Across its 28 recent EDGAR filings, KRAKacquisition Corp most often filed 3 (9), SCHEDULE 13G (3), 8-K (3), 10-Q (2). A selection from 2026-01-27 to 2026-01-27:

The full record for CIK 2082119 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2025-09-16. One example from this record is the SCHEDULE 13G filed 2026-02-06 (document). Insider trades for KRAKacquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lafayette acquisition lafayette acquisition corp.

Also searched as: "lafayette acquisition" | "lafayette acquisition corp."

This section ties “Lafayette acquisition lafayette acquisition corp.” to LaFayette Acquisition Corp. (ticker LAFA, LAFAR, LAFAU), SEC Central Index Key 2079106, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-11 by LaFayette Acquisition Corp. (CIK 2079106) — source document:

LaFayette Acquisition Corp. (the “Company”, “we”, “our”) is a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. We may pursue a business combination with a target in any industry or geographic region that we believe can benefit from the expertise and capabilities of our management team. The registration statement for the Company’s initial public offering (the “Initial Public Offering”) became effective on October 22, 2025. On October 27, 2025, the Company consummated the Initial Public Offering of 11,500,000 units (the “Units”), including 1,500,000 Units issued pursuant to the exercise of underwriters’ over-allotment option in full.

Financial trend for LaFayette Acquisition Corp. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) was tagged only for 2025-12-31 at $554,273; total assets went from $13,678 (2024-12-31) to $116.74 million (2025-12-31), a change of +853422.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2079106, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures LaFayette Acquisition Corp. did not tag for that period.

Deal and listing documents for LaFayette Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 4 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2025-10-24.

Current reports. Of the 3 8-K or 6-K reports in LaFayette Acquisition Corp.’s recent EDGAR index, the 3 listed here run from 2025-10-28 to 2025-11-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2079106 is on the EDGAR company page; the latest 10-K there is dated 2026-03-11 and the oldest filing in the recent index dates from 2025-08-05. Insider trades for LaFayette Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lafayette digital acquisition

Also searched as: "lafayette digital acquisition"

This section ties “Lafayette digital acquisition” to Lafayette Digital Acquisition Corp. I (ticker ZKP, ZKPU, ZKPW), SEC Central Index Key 2087447, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-25 by Lafayette Digital Acquisition Corp. I (CIK 2087447) — source document:

We are a blank check company incorporated in the Cayman Islands as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. We have neither engaged in any operations nor generated any revenue to date. Based on our business activities, the Company is a “shell company” as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) because we have no operations and nominal assets consisting almost entirely of cash. On August 27, 2025, we issued to our sponsor an aggregate of 9,583,333 Class B ordinary shares (the “founder shares”) for an aggregate purchase price of $25,000, or approximately $0.003 per share.

Financial trend for Lafayette Digital Acquisition Corp. I from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from $1.89 million (2026-03-31) to $2.38 million (2026-06-30), a change of +26.4%; total assets went from $290.80 million (2026-03-31) to $293.17 million (2026-06-30), a change of +0.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2087447, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Lafayette Digital Acquisition Corp. I did not tag for that period.

Deal and listing documents for Lafayette Digital Acquisition Corp. I — registration statements, prospectuses and merger proxies — are filed on EDGAR; 3 such filings (424B3, S-1, S-1/A) appear in its recent index, the newest dated 2026-01-12.

Current reports. Of the 3 8-K or 6-K reports in Lafayette Digital Acquisition Corp. I’s recent EDGAR index, the 3 listed here run from 2026-01-13 to 2026-01-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2087447 is on the EDGAR company page; the latest 10-K there is dated 2026-03-25 and the oldest filing in the recent index dates from 2025-09-23. Insider trades for Lafayette Digital Acquisition Corp. I appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

M evo global acquisition m evo global acquisition corp

Also searched as: "m evo global acquisition" | "m evo global acquisition corp"

This section ties “M evo global acquisition m evo global acquisition corp” to M Evo Global Acquisition Corp II (ticker MEVO, MEVOU, MEVOW), SEC Central Index Key 2087361, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 3 dated 2026-10-14. Nothing here is a recommendation to trade the security.

Financial trend for M Evo Global Acquisition Corp II from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from -$6.99 million (2026-03-31) to $2.57 million (2026-06-30), a change of +136.7%; total assets went from $302.92 million (2026-03-31) to $305.46 million (2026-06-30), a change of +0.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2087361, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures M Evo Global Acquisition Corp II did not tag for that period.

Deal and listing documents for M Evo Global Acquisition Corp II — registration statements, prospectuses and merger proxies — are filed on EDGAR; 5 such filings (424B4, S-1, S-1/A, S-1MEF) appear in its recent index, the newest dated 2026-02-02.

Current reports. Of the 5 8-K or 6-K reports in M Evo Global Acquisition Corp II’s recent EDGAR index, the 4 listed here run from 2026-02-06 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 29 recent EDGAR filings, M Evo Global Acquisition Corp II most often filed 3 (8), 8-K (5), SCHEDULE 13G (3), 10-Q (2). A selection from 2026-05-13 to 2026-10-14:

The full record for CIK 2087361 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-09-25. Insider trades for M Evo Global Acquisition Corp II appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Market technology acquisition

Also searched as: "market technology acquisition"

This section ties “Market technology acquisition” to Market Technology Acquisition Corp (ticker MTAK, MTAKU, MTAKW), SEC Central Index Key 2133136, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-16. Nothing here is a recommendation to trade the security.

Deal and listing documents for Market Technology Acquisition Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 4 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-07-27.

Current reports. Of the 3 8-K or 6-K reports in Market Technology Acquisition Corp’s recent EDGAR index, the 3 listed here run from 2026-07-28 to 2026-09-16, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 19 recent EDGAR filings, Market Technology Acquisition Corp most often filed 3 (5), 8-K (3), S-1/A (2), 10-Q (1). A selection from 2026-07-27 to 2026-09-03:

The full record for CIK 2133136 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-06-16. Insider trades for Market Technology Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Masonglory masonglory limited

Also searched as: "masonglory" | "masonglory limited"

This section ties “Masonglory masonglory limited” to Masonglory Ltd (ticker MSGY), SEC Central Index Key 2020228, an EDGAR registrant classified as “Construction - Special Trade Contractors” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a F-3 dated 2026-10-23. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-07-30 by Masonglory Ltd (CIK 2020228) — source document:

We are a holding company incorporated in the Cayman Islands with operations conducted in Hong Kong by our Operating Subsidiary, Masontech Limited. We have been engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong since 2018. As a subcontractor, we provide our customers with comprehensive wet trades works solutions, which principally include (i) plastering on floors, ceilings and walls, (ii) tile laying on internal and external walls and floors, (iii) brick laying, (iv) floor screeding, and (v) marble works. Our Operating Subsidiary, Masontech Limited, was incorporated as a company with limited liability under the laws of Hong Kong in September 2018.

Financial trend for Masonglory Ltd from annual reports, periods 2023-03-31 to 2026-03-31: revenue went from $7.95 million (2023-03-31) to $23.56 million (2026-03-31), a change of +196.2%; net income (loss) went from $332,354 (2023-03-31) to -$8.00 million (2026-03-31), a change of -2508.5%; total assets went from $7.69 million (2024-03-31) to $11.46 million (2026-03-31), a change of +49.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2020228, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Masonglory Ltd did not tag for that period.

Masonglory Ltd has 58 filings in its recent EDGAR index, including 2 annual reports and 0 quarterly reports; its newest filing is a F-3 from 2026-10-23.

Current reports. Of the 15 8-K or 6-K reports in Masonglory Ltd’s recent EDGAR index, the 4 listed here run from 2026-09-28 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2020228 is on the EDGAR company page; the latest 20-F there is dated 2026-07-30 and the oldest filing in the recent index dates from 2024-06-26. Insider trades for Masonglory Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Mckinley acquisition

Also searched as: "mckinley acquisition"

This section ties “Mckinley acquisition” to McKinley Acquisition Corp (ticker MKLY, MKLYR, MKLYU), SEC Central Index Key 2067592, an EDGAR registrant classified as “Services-Prepackaged Software” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a S-4/A dated 2026-10-05, and this view starts from filings dated on or before 2025-11-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-27 by McKinley Acquisition Corp (CIK 2067592) (passage 3, continuing from the earlier excerpt) — source document:

Their collective expertise spans public market transactions, private equity, M&A, financial restructuring, and operational optimization. Leveraging our team’s deep network of industry relationships and access to high-quality proprietary deal flow, we intend to identify a business combination target where our capital, strategic resources, and public company experience can accelerate growth, institutionalize operations, and drive long-term shareholder value. Investment Thesis Our investment strategy is guided by the thematic expertise and strategic insight of our management team and advisory board, with a specific focus on progressive industries — those experiencing accelerated innovation, structural change, and capital-intensive growth. We define progressive industries as segments within broader sectors that are being reshaped by technology, evolving consumer behavior, or regulatory transformation.

Financial trend for McKinley Acquisition Corp from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from $602,427 (2025-09-30) to $899,136 (2026-06-30), a change of +49.3%; total assets went from $175.51 million (2025-09-30) to $179.34 million (2026-06-30), a change of +2.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2067592, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures McKinley Acquisition Corp did not tag for that period.

Deal and listing documents for McKinley Acquisition Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 10 such filings (424B4, 425, S-1, S-1/A, S-4) appear in its recent index, the newest dated 2026-10-05.

Other filings. Across its 56 recent EDGAR filings, McKinley Acquisition Corp most often filed SCHEDULE 13G (8), 3 (8), CORRESP (8), 425 (5). A selection from 2026-02-13 to 2026-05-15:

The full record for CIK 2067592 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2025-05-09. One example from this record is the 8-K filed 2026-08-05 (document). Insider trades for McKinley Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Meridian3 industrials

Also searched as: "meridian3 industrials"

This section ties “Meridian3 industrials” to Meridian3 Industrials Acquisition Corp (ticker MIAC, MIACU, MIACW), SEC Central Index Key 2136530, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-08-21. Nothing here is a recommendation to trade the security.

Meridian3 Industrials Acquisition Corp has 27 filings in its recent EDGAR index, including 0 annual reports and 1 quarterly reports; its newest filing is a 8-K from 2026-08-21.

Current reports. Of the 3 8-K or 6-K reports in Meridian3 Industrials Acquisition Corp’s recent EDGAR index, the 3 listed here run from 2026-07-06 to 2026-08-21, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 27 recent EDGAR filings, Meridian3 Industrials Acquisition Corp most often filed 3 (10), 4 (6), 8-K (3), 10-Q (1). A selection from 2026-07-07 to 2026-08-10:

The full record for CIK 2136530 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-06-04. Insider trades for Meridian3 Industrials Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

National healthcare properties nhpreit.com

Also searched as: "national healthcare properties" | "nhpreit.com"

This section ties “National healthcare properties nhpreit.com” to National Healthcare Properties, Inc. (ticker NHP, HLTC), SEC Central Index Key 1561032, an EDGAR registrant classified as “Real Estate Investment Trusts” and organised in MD, formerly known as Healthcare Trust, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-22. Nothing here is a recommendation to trade the security.

Financial trend for National Healthcare Properties, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $335.85 million (2022-12-31) to $342.28 million (2025-12-31), a change of +1.9%; total assets went from $2.18 billion (2022-12-31) to $1.71 billion (2025-12-31), a change of -21.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1561032, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures National Healthcare Properties, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for National Healthcare Properties, Inc. (CIK 1561032) lists its business address as 540 MADISON AVE, 27TH FLOOR, NEW YORK, NY, which helps confirm you are on the right company’s site.

Current reports. Of the 225 8-K or 6-K reports in National Healthcare Properties, Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-10 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 564 recent EDGAR filings, National Healthcare Properties, Inc. most often filed 8-K (225), 4 (44), 10-Q (41), DEFA14A (30). A selection from 2026-08-19 to 2026-10-07:

The full record for CIK 1561032 is on the EDGAR company page; the latest 10-K there is dated 2026-02-20 and the oldest filing in the recent index dates from 2012-10-31. Insider trades for National Healthcare Properties, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

New century logistics new century logistics (bvi) nclogistics.com.hk

Also searched as: "new century logistics" | "new century logistics (bvi)" | "nclogistics.com.hk"

This section ties “New century logistics new century logistics (bvi) nclogistics.com.hk” to New Century Logistics (BVI) Ltd (ticker NCEW), SEC Central Index Key 1968043, an EDGAR registrant classified as “Arrangement of Transportation of Freight & Cargo” and organised in Virgin Islands, British. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G dated 2026-09-04. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-02-17 by New Century Logistics (BVI) Ltd (CIK 1968043) — source document:

NC Logistics was incorporated in the BVI on April 24, 2019 and is a holding company with no material operations. As part of the Reorganization, on May 10, 2019, the Company acquired NCL (HK), which is our principal operating subsidiary and is principally engaged in the business of freight forwarding and ancillary logistics services. NCL (HK) was incorporated in Hong Kong as a limited liability company on July 31, 2002, with an issued share capital of HK$1,000,000 divided into 1,000,000 shares. On September 26, 2019, the Company, via NCL (HK), has acquired NCEW (HK) and Win-Tec. NCEW (HK) is principally engaged in the business of freight forwarding services and Win-Tec is principally engaged in the business of warehousing and distribution services.

Financial trend for New Century Logistics (BVI) Ltd from annual reports, periods 2022-09-30 to 2025-09-30: revenue went from $75.19 million (2022-09-30) to $44.08 million (2025-09-30), a change of -41.4%; net income (loss) went from $6.98 million (2022-09-30) to -$10.67 million (2025-09-30), a change of -252.9%; total assets went from $15.80 million (2023-09-30) to $14.53 million (2025-09-30), a change of -8.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1968043, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures New Century Logistics (BVI) Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for New Century Logistics (BVI) Ltd (CIK 1968043) lists its business address as OFFICE A-E, 33/F, KING PALACE PLAZA,, HONG KONG, China, which helps confirm you are on the right company’s site.

Current reports. Of the 13 8-K or 6-K reports in New Century Logistics (BVI) Ltd’s recent EDGAR index, the 4 listed here run from 2025-11-07 to 2026-07-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1968043 is on the EDGAR company page; the latest 20-F there is dated 2026-02-17 and the oldest filing in the recent index dates from 2023-04-28. Insider trades for New Century Logistics (BVI) Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Northstrive acquisition northstrive acquisition corp

Also searched as: "northstrive acquisition" | "northstrive acquisition corp"

This section ties “Northstrive acquisition northstrive acquisition corp” to NorthStrive Acquisition Corp I. (ticker NSAI, NSAIR, NSAIU, NSAIW), SEC Central Index Key 2133719, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13D/A dated 2026-10-22. Nothing here is a recommendation to trade the security.

Deal and listing documents for NorthStrive Acquisition Corp I. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 3 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-08-19.

Current reports. Of the 4 8-K or 6-K reports in NorthStrive Acquisition Corp I.’s recent EDGAR index, the 4 listed here run from 2026-08-20 to 2026-09-14, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 26 recent EDGAR filings, NorthStrive Acquisition Corp I. most often filed 4 (7), 3 (6), 8-K (4), SCHEDULE 13D/A (1). A selection from 2026-10-22 to 2026-10-22:

The full record for CIK 2133719 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-07-22. Insider trades for NorthStrive Acquisition Corp I. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Odysight.ai odysight.ai inc. odysight.ai

Also searched as: "odysight.ai" | "odysight.ai inc." | "odysight.ai"

This section ties “Odysight.ai odysight.ai inc. odysight.ai” to Odysight.ai Inc. (ticker ODYS), SEC Central Index Key 1577445, an EDGAR registrant classified as “Services-Computer Integrated Systems Design” and organised in an unstated jurisdiction, formerly known as ScoutCam Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13D dated 2026-09-09. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-19 by Odysight.ai Inc. (CIK 1577445) — source document:

We are a pioneer in the development, production and marketing of innovative visual monitoring artificial intelligence, or AI, solutions that deploy small visual sensors to monitor critical safety components in hard-to-reach locations and harsh environments, across various PdM, and CBM use cases applied both for the civil and defense sectors. We aim to be the industry benchmark for real-time, visual-based machine and infrastructure health monitoring and predictive maintenance analysis through AI and machine learning data analytics. Our Mission We aim to become the industry standard for real time, visual based, health monitoring using AI/ML data analytics. Our Solutions Our solutions stream visual information to our processing unit, an in-platform, high-performance AI/ML (machine learning) computer, allowing maintenance and operations teams, on the ground and during operations, visibility into areas that are inaccessible under normal operating conditions or where conditions are not suitable for continuous monitoring.

Financial trend for Odysight.ai Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $665,000 (2022-12-31) to $3.02 million (2025-12-31), a change of +353.4%; net income (loss) went from -$9.47 million (2022-12-31) to -$17.04 million (2025-12-31), a change of -79.9%; total assets went from $16.89 million (2022-12-31) to $28.98 million (2025-12-31), a change of +71.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1577445, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Odysight.ai Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Odysight.ai Inc. (CIK 1577445) lists its business address as 14201 N. HAYDEN ROAD, SUITE A-1, SCOTTSDALE, AZ, which helps confirm you are on the right company’s site.

Current reports. Of the 96 8-K or 6-K reports in Odysight.ai Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-05 to 2026-08-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1577445 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2013-05-29. Insider trades for Odysight.ai Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Oms energy technologies oms energy technologies inc omsos.com

Also searched as: "oms energy technologies" | "oms energy technologies inc" | "omsos.com"

This section ties “Oms energy technologies oms energy technologies inc omsos.com” to OMS Energy Technologies Inc. (ticker OMSE), SEC Central Index Key 2012219, an EDGAR registrant classified as “Oil & Gas Field Machinery & Equipment” and organised in an unstated jurisdiction. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 20-F/A dated 2026-10-22. Nothing here is a recommendation to trade the security.

Financial trend for OMS Energy Technologies Inc. from annual reports, periods 2023-03-31 to 2025-03-31: revenue went from $97.46 million (2023-03-31) to $203.61 million (2025-03-31), a change of +108.9%; net income (loss) went from $12.42 million (2023-03-31) to $46.98 million (2025-03-31), a change of +278.2%; total assets went from $100.11 million (2023-03-31) to $170.50 million (2025-03-31), a change of +70.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2012219, tags Assets, ProfitLoss, Revenue; 3 periods shown, dashes mark figures OMS Energy Technologies Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for OMS Energy Technologies Inc. (CIK 2012219) lists its business address as 10 GUL CIRCLE, SINGAPORE, which helps confirm you are on the right company’s site.

Current reports. Of the 4 8-K or 6-K reports in OMS Energy Technologies Inc.’s recent EDGAR index, the 4 listed here run from 2025-07-24 to 2026-06-25, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 53 recent EDGAR filings, OMS Energy Technologies Inc. most often filed F-1/A (10), CORRESP (10), UPLOAD (9), 3 (6). A selection from 2026-03-24 to 2026-10-22:

The full record for CIK 2012219 is on the EDGAR company page; the latest 20-F there is dated 2026-06-25 and the oldest filing in the recent index dates from 2024-05-29. Insider trades for OMS Energy Technologies Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Orangekloud orangekloud technology orangekloud technology inc

Also searched as: "orangekloud" | "orangekloud technology" | "orangekloud technology inc"

This section ties “Orangekloud orangekloud technology orangekloud technology inc” to ORANGEKLOUD TECHNOLOGY INC. (ticker ORKT), SEC Central Index Key 1979407, an EDGAR registrant classified as “Services-Prepackaged Software” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-22. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-30 by ORANGEKLOUD TECHNOLOGY INC. (CIK 1979407) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 46 A. Operating results. 48 B. Liquidity and capital resources. 53 C. Research and development, patents and licenses, etc. 57 D. Trend information. 57 E. Critical accounting estimates 57 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 59 A. Directors and senior management. 59 B. Compensation. 62 C. Board Practices. 63 D. Employees. 67 E. Share Ownership. 67 F. Disclosure of a registrant’s action to recover erroneously awarded compensation. 67 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 68 A. Major Shareholders. 68 B. Related Party Transactions. 68 C. Interests of Experts and Counsel 68 ITEM 8. FINANCIAL INFORMATION 68 A. Consolidated Statements and Other Financial Information. 68 B. Significant Changes. 69 ITEM 9.

Financial trend for ORANGEKLOUD TECHNOLOGY INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 7,152,092 SGD (2022-12-31) to 5,682,839 SGD (2025-12-31), a change of -20.5%; net income (loss) went from 1,987,887 SGD (2022-12-31) to -4,471,234 SGD (2025-12-31), a change of -324.9%; total assets went from 4,224,139 SGD (2023-12-31) to 11,850,279 SGD (2025-12-31), a change of +180.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1979407, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures ORANGEKLOUD TECHNOLOGY INC. did not tag for that period.

ORANGEKLOUD TECHNOLOGY INC. has 88 filings in its recent EDGAR index, including 2 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-22.

Current reports. Of the 27 8-K or 6-K reports in ORANGEKLOUD TECHNOLOGY INC.’s recent EDGAR index, the 4 listed here run from 2026-03-16 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1979407 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2023-07-06. Insider trades for ORANGEKLOUD TECHNOLOGY INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Park dental partners park dental partners inc. parkdentalpartners.com

Also searched as: "park dental partners" | "park dental partners inc." | "parkdentalpartners.com"

This section ties “Park dental partners park dental partners inc. parkdentalpartners.com” to Park Dental Partners, Inc. (ticker PARK), SEC Central Index Key 2069604, an EDGAR registrant classified as “Services-Misc Health & Allied Services, NEC” and organised in MN. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-10-15. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-25 by Park Dental Partners, Inc. (CIK 2069604) — source document:

As a dental resource organization (“DRO”), Park Dental Partners, Inc. provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to our affiliated general and multi-specialty dental practices in Minnesota, Wisconsin and Arizona. Our network of affiliated dental practices employs 214 dentists, and consists of 990 hygienists, dental assistants, and patient care coordinators that support affiliated dentists in operating their dental practices across 86 practice locations. Our network of affiliated dental practices has been operating for over fifty years, beginning with the establishment of the general dentistry group in 1972. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health.

Financial trend for Park Dental Partners, Inc. from quarterly and annual reports (three-month periods), periods 2025-06-30 to 2026-06-30: revenue went from $63.00 million (2025-06-30) to $66.21 million (2026-06-30), a change of +5.1%; net income (loss) went from $2.57 million (2025-06-30) to $1.35 million (2026-06-30), a change of -47.5%; total assets went from $179.86 million (2026-03-31) to $186.27 million (2026-06-30), a change of +3.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2069604, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Park Dental Partners, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Park Dental Partners, Inc. (CIK 2069604) lists its business address as 2200 COUNTY ROAD C WEST, ROSEVILLE, MN, which helps confirm you are on the right company’s site.

Current reports. Of the 10 8-K or 6-K reports in Park Dental Partners, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-10 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2069604 is on the EDGAR company page; the latest 10-K there is dated 2026-03-25 and the oldest filing in the recent index dates from 2025-05-21. Insider trades for Park Dental Partners, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Park ha biological technology parkha.cn

Also searched as: "park ha biological technology" | "parkha.cn"

This section ties “Park ha biological technology parkha.cn” to Park Ha Biological Technology Co., Ltd. (ticker BYAH), SEC Central Index Key 1986247, an EDGAR registrant classified as “Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics” and organised in China. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-09-11. Nothing here is a recommendation to trade the security.

Financial trend for Park Ha Biological Technology Co., Ltd. from annual reports, periods 2022-10-31 to 2025-10-31: revenue went from $1.92 million (2022-10-31) to $2.52 million (2025-10-31), a change of +31.5%; net income (loss) went from $191,298 (2022-10-31) to -$24.36 million (2025-10-31), a change of -12836.5%; total assets went from $2.26 million (2023-10-31) to $5.95 million (2025-10-31), a change of +162.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1986247, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Park Ha Biological Technology Co., Ltd. did not tag for that period.

Park Ha Biological Technology Co., Ltd. has 97 filings in its recent EDGAR index, including 2 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-09-11.

Current reports. Of the 31 8-K or 6-K reports in Park Ha Biological Technology Co., Ltd.’s recent EDGAR index, the 4 listed here run from 2026-08-03 to 2026-09-11, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 97 recent EDGAR filings, Park Ha Biological Technology Co., Ltd. most often filed 6-K (31), CORRESP (9), SCHEDULE 13G (8), F-1/A (8). A selection from 2026-08-10 to 2026-08-13:

The full record for CIK 1986247 is on the EDGAR company page; the latest 20-F there is dated 2026-03-02 and the oldest filing in the recent index dates from 2023-12-29. Insider trades for Park Ha Biological Technology Co., Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pinnacle food pinnacle food group pinnaclefoodinc.com

Also searched as: "pinnacle food" | "pinnacle food group" | "pinnaclefoodinc.com"

This section ties “Pinnacle food pinnacle food group pinnaclefoodinc.com” to Pinnacle Food Group Ltd (ticker PFAI), SEC Central Index Key 2032755, an EDGAR registrant classified as “Agricultural Services” and organised in United States. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a S-8 dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-30 by Pinnacle Food Group Ltd (CIK 2032755) — source document:

On November 3, 2015, our predecessor, Pinnacle Coffee Inc., was established in Vancouver, Canada. On March 15, 2016, Pinnacle Coffee Inc. changed its name to Pinnacle Food Inc. (“Pinnacle Canada”) to reflect a shift in focus towards the processing and export of Ginseng products to Asian countries. Starting in 2022, Pinnacle Canada began focusing on smart agricultural services. Starting in 2023, Pinnacle Canada began offering hydroponic growing systems with integrated advanced technologies and related technical and consultation support. Before the Reorganization described below, Ms. Li Xia Du (“Ms. Du”) was the sole shareholder of Pinnacle Canada, owning all of its issued and outstanding common shares. On November 2023, Pinnacle Food Group Limited (“Pinnacle Cayman”) was incorporated in the Cayman Islands under the Companies Act as an exempted company with limited liability.

Financial trend for Pinnacle Food Group Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $177,326 (2022-12-31) to $3.41 million (2025-12-31), a change of +1824.7%; net income (loss) went from -$205,158 (2022-12-31) to -$1.90 million (2025-12-31), a change of -828.0%; total assets went from $3.82 million (2023-12-31) to $10.29 million (2025-12-31), a change of +169.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2032755, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Pinnacle Food Group Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Pinnacle Food Group Ltd (CIK 2032755) lists its business address as 600 837 WEST HASTINGS STREET, VANCOUVER, British Columbia, Canada, which helps confirm you are on the right company’s site.

Current reports. Of the 14 8-K or 6-K reports in Pinnacle Food Group Ltd’s recent EDGAR index, the 4 listed here run from 2026-06-05 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2032755 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2024-08-23. Insider trades for Pinnacle Food Group Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Planet image international yibomk.com

Also searched as: "planet image international" | "yibomk.com"

This section ties “Planet image international yibomk.com” to Planet Image International Ltd (ticker YIBO), SEC Central Index Key 1868395, an EDGAR registrant classified as “Computer Peripheral Equipment, NEC” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-09-16. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-03-31 by Planet Image International Ltd (CIK 1868395) — source document:

Qilong Yang and other shareholders established our operating subsidiaries, Jiangxi Yibo in January 2011 and Aster BVI in February 2011, respectively. In March 2011, Aster US was formed in the State of California as a limited liability company, which later served as our sales headquarter for the North American market. Aster US functions as a wholesaler and distributor and interacts with retailers, resellers, and dealers in the North American market. Since its inception, Aster US has focused its operations on the offline sales to customers and dealers in the North American market and has not conducted any e-commerce related business. In July 2011, Aster NL was formed in the Netherlands as a limited liability company, which later became our headquarter serving mainly the European market.

Financial trend for Planet Image International Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $142.13 million (2022-12-31) to $155.25 million (2025-12-31), a change of +9.2%; net income (loss) went from $7.24 million (2022-12-31) to -$8.25 million (2025-12-31), a change of -214.0%; total assets went from $118.62 million (2022-12-31) to $154.15 million (2025-12-31), a change of +29.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1868395, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Planet Image International Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Planet Image International Ltd (CIK 1868395) lists its business address as NO. 756 GUANGFU ROAD, XINYU CITY, JIANGXI PROVINCE, which helps confirm you are on the right company’s site.

Current reports. Of the 11 8-K or 6-K reports in Planet Image International Ltd’s recent EDGAR index, the 4 listed here run from 2025-12-04 to 2026-09-16, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1868395 is on the EDGAR company page; the latest 20-F there is dated 2026-03-31 and the oldest filing in the recent index dates from 2021-08-30. Insider trades for Planet Image International Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pomdoctor pomdoctor limited 7lk.com

Also searched as: "pomdoctor" | "pomdoctor limited" | "7lk.com"

This section ties “Pomdoctor pomdoctor limited 7lk.com” to POMDOCTOR Ltd (ticker POM), SEC Central Index Key 1877971, an EDGAR registrant classified as “Retail-Miscellaneous Retail” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-05-14 by POMDOCTOR Ltd (CIK 1877971) — source document:

To facilitate the growth of our business, we incorporated or acquired various PRC operating entities including Guangzhou Qilekang Modern Pharmaceutical Logistics Co., Ltd. and Hangzhou Qilekang Pharmaceutical Co., Ltd. With the growth of our business and in order to facilitate international capital investment in us, we started a reorganization as described below involving new offshore and onshore entities in March 2021. In February 2021, we incorporated POMDOCTOR LIMITED as our proposed listing entity in the Cayman Islands. Further, POMEGRANATE CLOUD MEDICAL LIMITED was established in Hong Kong in March 2021 and Guangzhou Pomegranate Cloud Medical Health Medical Technology Co., Ltd. was established in the PRC in April 2021. In May 2021, Guangzhou Qilekang Pharmaceutical Chain Co., Ltd. was renamed as Guangzhou Qilekang Digital Health Medical Technology Co., Ltd., or Qilekang Digital Health.

Financial trend for POMDOCTOR Ltd from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from 304,852,971 CNY (2023-12-31) to 399,914,964 CNY (2025-12-31), a change of +31.2%; net income (loss) went from -36,949,421 CNY (2023-12-31) to -130,931,921 CNY (2025-12-31), a change of -254.4%; total assets went from 46,227,586 CNY (2024-12-31) to 107,557,426 CNY (2025-12-31), a change of +132.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1877971, tags Assets, ProfitLoss, Revenues; 3 periods shown, dashes mark figures POMDOCTOR Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for POMDOCTOR Ltd (CIK 1877971) lists its business address as YONGXU INDUSTRIAL PARK, GUANGZHOU, which helps confirm you are on the right company’s site.

Current reports. Of the 24 8-K or 6-K reports in POMDOCTOR Ltd’s recent EDGAR index, the 4 listed here run from 2026-09-30 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1877971 is on the EDGAR company page; the latest 20-F there is dated 2026-05-14 and the oldest filing in the recent index dates from 2021-09-30. Insider trades for POMDOCTOR Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Procap acquisition procap acquisition corp

Also searched as: "procap acquisition" | "procap acquisition corp"

This section ties “Procap acquisition procap acquisition corp” to ProCap Acquisition Corp (ticker PCAP, PCAPU, PCAPW), SEC Central Index Key 2056634, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-08-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-17 by ProCap Acquisition Corp (CIK 2056634) — source document:

We are a blank check company incorporated on January 2, 2025 as a Cayman Islands exempted company and formed for the purpose of effecting a Business Combination with one or more businesses or entities. To date, we have not selected any Business Combination target and our efforts have been limited to (i) organizational activities, (ii) activities related to our Initial Public Offering, and (iii) searching for a Business Combination target. We have also generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial Business Combination. We may pursue an initial Business Combination target in any business or industry or at any stage of its corporate evolution.

Financial trend for ProCap Acquisition Corp from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from $2.47 million (2025-09-30) to $2.05 million (2026-06-30), a change of -17.0%; total assets went from $255.04 million (2025-09-30) to $261.20 million (2026-06-30), a change of +2.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2056634, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures ProCap Acquisition Corp did not tag for that period.

Deal and listing documents for ProCap Acquisition Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 5 such filings (424B4, S-1, S-1/A, S-1MEF) appear in its recent index, the newest dated 2025-05-22.

Current reports. Of the 3 8-K or 6-K reports in ProCap Acquisition Corp’s recent EDGAR index, the 3 listed here run from 2025-05-27 to 2025-07-10, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2056634 is on the EDGAR company page; the latest 10-K there is dated 2026-03-17 and the oldest filing in the recent index dates from 2025-02-20. Insider trades for ProCap Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Propanc biopharma propanc biopharma inc. propanc.com

Also searched as: "propanc biopharma" | "propanc biopharma inc." | "propanc.com"

This section ties “Propanc biopharma propanc biopharma inc. propanc.com” to Propanc Biopharma, Inc. (ticker PPCB), SEC Central Index Key 1517681, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as Propanc Health Group Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a DEF 14C dated 2026-10-21. Nothing here is a recommendation to trade the security.

Financial trend for Propanc Biopharma, Inc. from annual reports, periods 2023-06-30 to 2026-06-30: net income (loss) went from -$2.66 million (2023-06-30) to -$18.86 million (2026-06-30), a change of -609.0%; total assets went from $60,328 (2023-06-30) to $12.78 million (2026-06-30), a change of +21084.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1517681, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Propanc Biopharma, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Propanc Biopharma, Inc. (CIK 1517681) lists its business address as 302/6 BUTLER STREET, CAMBERWELL, VICTORIA, Australia, which helps confirm you are on the right company’s site.

Current reports. Of the 129 8-K or 6-K reports in Propanc Biopharma, Inc.’s recent EDGAR index, the 4 listed here run from 2025-11-10 to 2026-07-14, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 437 recent EDGAR filings, Propanc Biopharma, Inc. most often filed 8-K (129), 10-Q (44), CORRESP (37), 424B3 (25). A selection from 2026-08-21 to 2026-10-21:

The full record for CIK 1517681 is on the EDGAR company page; the latest 10-K there is dated 2026-09-25 and the oldest filing in the recent index dates from 2011-06-23. Insider trades for Propanc Biopharma, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Quanome technologies quanome technologies inc. lakesideholding.com

Also searched as: "quanome technologies" | "quanome technologies inc." | "lakesideholding.com"

This section ties “Quanome technologies quanome technologies inc. lakesideholding.com” to Quanome Technologies, Inc. (ticker QNME), SEC Central Index Key 1996192, an EDGAR registrant classified as “Arrangement of Transportation of Freight & Cargo” and organised in NV, formerly known as Lakeside Holding Ltd. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-21. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-09-25 by Quanome Technologies, Inc. (CIK 1996192) — source document:

Prior to February 12, 2026, in addition to engaging in the distribution of pharmaceutical products through Hupan Pharmaceutical, we also operated as a U.S.-based integrated cross-border supply chain solutions provider with a strategic focus on the Asian market. On February 12, 2026, we transferred the operations of ABL Chicago to an unrelated third party, which obtained operational control and substantially all economic interests associated with the business. Following the transfer, we ceased substantive involvement in ABL Chicago’s cross-border freight forwarding and logistics business. Our revenue from continuing pharmaceutical operations was primarily derived from selling infusion products, foods for special medical purposes, and specialty pharmaceuticals to hospitals, pharmaceutical distributors and other healthcare providers.

Financial trend for Quanome Technologies, Inc. from annual reports, periods 2023-06-30 to 2026-06-30: revenue went from $12.87 million (2023-06-30) to $5.85 million (2026-06-30), a change of -54.6%; net income (loss) went from $983,602 (2023-06-30) to -$9.48 million (2026-06-30), a change of -1064.2%; total assets went from $5.47 million (2023-06-30) to $11.65 million (2026-06-30), a change of +113.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1996192, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Quanome Technologies, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Quanome Technologies, Inc. (CIK 1996192) lists its business address as 1475 THORNDALE AVE SUITE A, ITASCA, IL, which helps confirm you are on the right company’s site.

Current reports. Of the 39 8-K or 6-K reports in Quanome Technologies, Inc.’s recent EDGAR index, the 4 listed here run from 2026-10-01 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1996192 is on the EDGAR company page; the latest 10-K there is dated 2026-09-25 and the oldest filing in the recent index dates from 2023-10-30. Insider trades for Quanome Technologies, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Quest resource quest resource holding qrhc.com

Also searched as: "quest resource" | "quest resource holding" | "qrhc.com"

This section ties “Quest resource quest resource holding qrhc.com” to Quest Resource Holding Corp (ticker QRHC), SEC Central Index Key 1442236, an EDGAR registrant classified as “Refuse Systems” and organised in NV, formerly known as Infinity Resources Holdings Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-02. Nothing here is a recommendation to trade the security.

Financial trend for Quest Resource Holding Corp from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$6.05 million (2022-12-31) to -$15.38 million (2025-12-31), a change of -154.3%; total assets went from $181.49 million (2022-12-31) to $145.55 million (2025-12-31), a change of -19.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1442236, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Quest Resource Holding Corp did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Quest Resource Holding Corp (CIK 1442236) lists its business address as 433 E. LAS COLINAS BOULEVARD, IRVING, TX, which helps confirm you are on the right company’s site.

Current reports. Of the 158 8-K or 6-K reports in Quest Resource Holding Corp’s recent EDGAR index, the 4 listed here run from 2026-03-23 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 886 recent EDGAR filings, Quest Resource Holding Corp most often filed 4 (430), 8-K (158), 10-Q (54), 3 (38). A selection from 2026-10-02 to 2026-10-02:

The full record for CIK 1442236 is on the EDGAR company page; the latest 10-K there is dated 2026-03-13 and the oldest filing in the recent index dates from 2008-08-12. Insider trades for Quest Resource Holding Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rare earths americas rare earths americas inc. rareearthsamericas.com

Also searched as: "rare earths americas" | "rare earths americas inc." | "rareearthsamericas.com"

This section ties “Rare earths americas rare earths americas inc. rareearthsamericas.com” to Rare Earths Americas, Inc. (ticker REA), SEC Central Index Key 2095743, an EDGAR registrant classified as “Metal Mining” and organised in TX. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a ARS dated 2026-09-28. Nothing here is a recommendation to trade the security.

Financial trend for Rare Earths Americas, Inc. from quarterly and annual reports (three-month periods), periods 2025-06-30 to 2026-06-30: net income (loss) went from -$601,000 (2025-06-30) to -$12.79 million (2026-06-30), a change of -2028.1%; total assets went from $47.44 million (2026-03-31) to $102.38 million (2026-06-30), a change of +115.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2095743, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Rare Earths Americas, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Rare Earths Americas, Inc. (CIK 2095743) lists its business address as 101 W. MAIN STREET, MANCHESTER, GA, which helps confirm you are on the right company’s site.

Current reports. Of the 5 8-K or 6-K reports in Rare Earths Americas, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-16 to 2026-08-25, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 54 recent EDGAR filings, Rare Earths Americas, Inc. most often filed 4 (17), 3 (9), SCHEDULE 13G (6), 8-K (5). A selection from 2026-08-24 to 2026-09-28:

The full record for CIK 2095743 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-11-12. Insider trades for Rare Earths Americas, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rmg ml sports rmg ml sports holdings

Also searched as: "rmg ml sports" | "rmg ml sports holdings"

This section ties “Rmg ml sports rmg ml sports holdings” to RMG ML Sports Holdings (ticker SHOT, SHOTR, SHOTU), SEC Central Index Key 2104879, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-12. Nothing here is a recommendation to trade the security.

Financial trend for RMG ML Sports Holdings from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from -$70,301 (2026-03-31) to -$6.14 million (2026-06-30), a change of -8628.3%; total assets was tagged only for 2026-06-30 at $218.19 million. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2104879, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures RMG ML Sports Holdings did not tag for that period.

RMG ML Sports Holdings has 23 filings in its recent EDGAR index, including 0 annual reports and 1 quarterly reports; its newest filing is a 10-Q from 2026-08-12.

Current reports. Of the 4 8-K or 6-K reports in RMG ML Sports Holdings’s recent EDGAR index, the 4 listed here run from 2026-06-11 to 2026-07-13, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 23 recent EDGAR filings, RMG ML Sports Holdings most often filed 3 (6), 8-K (4), SCHEDULE 13G (2), CORRESP (2). A selection from 2026-06-09 to 2026-08-12:

The full record for CIK 2104879 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-01-29. Insider trades for RMG ML Sports Holdings appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Serina therapeutics serina therapeutics inc. serinatherapeutics.com

Also searched as: "serina therapeutics" | "serina therapeutics inc." | "serinatherapeutics.com"

This section ties “Serina therapeutics serina therapeutics inc. serinatherapeutics.com” to Serina Therapeutics, Inc. (ticker SER), SEC Central Index Key 1708599, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in AL, formerly known as AgeX Therapeutics, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-09. Nothing here is a recommendation to trade the security.

Financial trend for Serina Therapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $34,000 (2022-12-31) to $130,000 (2025-12-31), a change of +282.4%; net income (loss) went from -$10.46 million (2022-12-31) to -$19.18 million (2025-12-31), a change of -83.3%; total assets went from $3.24 million (2022-12-31) to $6.95 million (2025-12-31), a change of +114.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1708599, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Serina Therapeutics, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Serina Therapeutics, Inc. (CIK 1708599) lists its business address as 601 GENOME WAY, HUNTSVILLE, AL, which helps confirm you are on the right company’s site.

Current reports. Of the 153 8-K or 6-K reports in Serina Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-13 to 2026-10-09, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 518 recent EDGAR filings, Serina Therapeutics, Inc. most often filed 8-K (153), 4 (143), SC 13D/A (36), 3 (29). A selection from 2026-07-23 to 2026-08-31:

The full record for CIK 1708599 is on the EDGAR company page; the latest 10-K/A there is dated 2026-03-27 and the oldest filing in the recent index dates from 2017-07-10. Insider trades for Serina Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ss innovations international ssinnovations.com

Also searched as: "ss innovations international" | "ssinnovations.com"

This section ties “Ss innovations international ssinnovations.com” to SS Innovations International, Inc. (ticker SSII), SEC Central Index Key 1676163, an EDGAR registrant classified as “Surgical & Medical Instruments & Apparatus” and organised in FL, formerly known as SS Innovations International, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-10 by SS Innovations International, Inc. (CIK 1676163) — source document:

We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “ SSi Mantra ”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries. While surgical robotic systems have gained acceptance globally in the past two decades for providing greater efficiency, better clinical outcomes and reducing healthcare costs, access to such systems remains largely limited to developed countries such as the United States (the “ U.S. ”), the European Union (the “ EU ”) and Japan.

Financial trend for SS Innovations International, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.44 million (2022-12-31) to $42.48 million (2025-12-31), a change of +2858.2%; net income (loss) went from -$3.21 million (2022-12-31) to -$12.13 million (2025-12-31), a change of -277.3%; total assets went from $6.98 million (2022-12-31) to $74.23 million (2025-12-31), a change of +963.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1676163, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures SS Innovations International, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for SS Innovations International, Inc. (CIK 1676163) lists its business address as 405, 3RD FLOOR, ILABS INFO TECH CENTRE, GURUGRAM, which helps confirm you are on the right company’s site.

Current reports. Of the 113 8-K or 6-K reports in SS Innovations International, Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-10 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1676163 is on the EDGAR company page; the latest 10-K/A there is dated 2026-03-31 and the oldest filing in the recent index dates from 2016-06-03. Insider trades for SS Innovations International, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Sunshine biopharma sunshine biopharma inc. sunshinebiopharma.com

Also searched as: "sunshine biopharma" | "sunshine biopharma inc." | "sunshinebiopharma.com"

This section ties “Sunshine biopharma sunshine biopharma inc. sunshinebiopharma.com” to Sunshine Biopharma Inc. (ticker SBFM, SBFMW), SEC Central Index Key 1402328, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in CO, formerly known as Sunshine Biopharma, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a PRE 14C dated 2026-10-14. Nothing here is a recommendation to trade the security.

Financial trend for Sunshine Biopharma Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $4.35 million (2022-12-31) to $36.31 million (2025-12-31), a change of +735.5%; net income (loss) went from -$26.74 million (2022-12-31) to -$5.98 million (2025-12-31), a change of +77.7%; total assets went from $29.24 million (2022-12-31) to $30.08 million (2025-12-31), a change of +2.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1402328, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Sunshine Biopharma Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Sunshine Biopharma Inc. (CIK 1402328) lists its business address as 333 LAS OLAS WAY, FORT LAUDERDALE, FL, which helps confirm you are on the right company’s site.

Current reports. Of the 98 8-K or 6-K reports in Sunshine Biopharma Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-11 to 2026-10-14, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 427 recent EDGAR filings, Sunshine Biopharma Inc. most often filed 8-K (98), 10-Q (54), 4 (40), CORRESP (19). A selection from 2026-10-07 to 2026-10-14:

The full record for CIK 1402328 is on the EDGAR company page; the latest 10-K there is dated 2026-04-03 and the oldest filing in the recent index dates from 2007-05-25. Insider trades for Sunshine Biopharma Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Texas ventures acquisition iii

Also searched as: "texas ventures acquisition iii"

This section ties “Texas ventures acquisition iii” to Texas Ventures Acquisition III Corp (ticker TVA, TVACU, TVACW), SEC Central Index Key 2033991, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-21. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-04-15 by Texas Ventures Acquisition III Corp (CIK 2033991) — source document:

References in this Annual Report on Form 10-K (the “Annual Report” or the “Form 10-K”) to “we,” “us,” “our”, “Texas Ventures” or the “Company” refer to Texas Ventures Acquisition III Corp. Overview We are a blank check company incorporated on July 26, 2024, as a Cayman Islands exempted company with no material operations of our own. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We may pursue an initial Business Combination in any business or industry. Our units include shares of a Cayman Islands blank check company instead of the shares of the operating entities with whom we may combine.

Financial trend for Texas Ventures Acquisition III Corp from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) was tagged only for 2025-12-31 at $5.93 million; total assets went from $255,223 (2024-12-31) to $233.45 million (2025-12-31), a change of +91370.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2033991, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Texas Ventures Acquisition III Corp did not tag for that period.

Deal and listing documents for Texas Ventures Acquisition III Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 10 such filings (424B4, 425, S-1, S-1/A, S-4) appear in its recent index, the newest dated 2026-10-13.

Current reports. Of the 13 8-K or 6-K reports in Texas Ventures Acquisition III Corp’s recent EDGAR index, the 4 listed here run from 2026-09-03 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2033991 is on the EDGAR company page; the latest 10-K there is dated 2026-04-15 and the oldest filing in the recent index dates from 2024-10-04. Insider trades for Texas Ventures Acquisition III Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Texxon texxon holding texxon holding limited nptcn.com

Also searched as: "texxon" | "texxon holding" | "texxon holding limited" | "nptcn.com"

This section ties “Texxon texxon holding texxon holding limited nptcn.com” to Texxon Holding Ltd (ticker NPT), SEC Central Index Key 2014337, an EDGAR registrant classified as “Wholesale-Chemicals & Allied Products” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-06-30. Nothing here is a recommendation to trade the security.

Financial trend for Texxon Holding Ltd from annual reports, periods 2023-06-30 to 2025-06-30: revenue went from $552.53 million (2023-06-30) to $797.15 million (2025-06-30), a change of +44.3%; net income (loss) went from $2.02 million (2023-06-30) to -$932,621 (2025-06-30), a change of -146.1%; total assets went from $74.91 million (2023-06-30) to $138.97 million (2025-06-30), a change of +85.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2014337, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Texxon Holding Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Texxon Holding Ltd (CIK 2014337) lists its business address as 7A, BLOCK C, 207 SONGHONG RD, SHANGHAI, which helps confirm you are on the right company’s site.

Current reports. Of the 5 8-K or 6-K reports in Texxon Holding Ltd’s recent EDGAR index, the 4 listed here run from 2025-10-28 to 2026-06-30, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 50 recent EDGAR filings, Texxon Holding Ltd most often filed CORRESP (11), UPLOAD (8), 6-K (5), 3 (5). A selection from 2026-03-30 to 2026-04-15:

The full record for CIK 2014337 is on the EDGAR company page; the latest 20-F there is dated 2025-11-18 and the oldest filing in the recent index dates from 2024-03-26. Insider trades for Texxon Holding Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Theriva biologics theriva biologics inc. therivabio.com

Also searched as: "theriva biologics" | "theriva biologics inc." | "therivabio.com"

This section ties “Theriva biologics theriva biologics inc. therivabio.com” to Theriva Biologics, Inc. (ticker TOVX), SEC Central Index Key 894158, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in NV, formerly known as Synthetic Biologics, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a DEF 14A dated 2026-10-20. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-12 by Theriva Biologics, Inc. (CIK 894158) — source document:

We are a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. As a result of the Company’s acquisition of Theriva Biologics, S.L. (“VCN”, formerly named VCN Biosciences, S.L.), in March 2022, as described in more detail below (the “Acquisition”), we transitioned our strategic focus to oncology through the development of VCN’s new oncolytic adenovirus platform designed for intravenous and intravitreal delivery to trigger tumor cell death, to improve access of co-administered cancer therapies to the tumor, and to promote a robust and sustained anti-tumor response by the patient’s immune system. Our lead product candidate, VCN - 01 (zabilugene almadenorepvec), is a clinical stage oncolytic human adenovirus that is modified for tumor - selective replication and to express an enzyme, PH20 hyaluronidase.

Financial trend for Theriva Biologics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$19.68 million (2022-12-31) to -$18.35 million (2023-12-31), a change of +6.8%; total assets went from $71.86 million (2022-12-31) to $38.24 million (2025-12-31), a change of -46.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 894158, tags Assets, NetIncomeLoss, SalesRevenueNet; 4 periods shown, dashes mark figures Theriva Biologics, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Theriva Biologics, Inc. (CIK 894158) lists its business address as 9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, which helps confirm you are on the right company’s site.

Current reports. Of the 350 8-K or 6-K reports in Theriva Biologics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-07 to 2026-08-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 894158 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 1998-06-23. Insider trades for Theriva Biologics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Thunder bridge capital

Also searched as: "thunder bridge capital"

What this search refers to. “Thunder Bridge Capital” is the sponsor brand behind several SPACs (Thunder Bridge Capital Partners III, IV and others), each a separate SEC registrant; the EDGAR name search shows all of them. Official source: www.sec.gov.

No SEC filer could be matched to “Thunder bridge capital” with a single, clear Central Index Key: the phrase “Thunder bridge capital” appears in 2806+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “thunder” (search terms considered: thunder, bridge, capital).

In the 100 most relevant full-text hits returned for “Thunder bridge capital”, filings range from 2019-07-29 to 2026-09-18. The filers whose documents mention it most often are Thunder Bridge Capital Partners IV, Inc. (THCP, THCPU, THCPW) (CIK 0001843993) (55 hits); Thunder Bridge Capital Partners III Inc. (CIK 0001815753) (30 hits); Thunder Bridge Capital Partners V, Ltd. (TBCV) (CIK 0002140030) (8 hits); Coincheck Group B.V. (CNCK) (CIK 0001913847) (7 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 86 entities whose registered name contains the word “thunder”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “thunder” 86, “bridge” 484, “capital” 482. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: if “thunder” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Turn therapeutics turn therapeutics inc. turntherapeutics.com

Also searched as: "turn therapeutics" | "turn therapeutics inc." | "turntherapeutics.com"

This section ties “Turn therapeutics turn therapeutics inc. turntherapeutics.com” to Turn Therapeutics Inc. (ticker TTRX), SEC Central Index Key 2023016, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as Global Health Solutions, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a ARS dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-31 by Turn Therapeutics Inc. (CIK 2023016) — source document:

Unless the context otherwise requires, for purposes of this section, the terms “we,” “us,” or “the Company” or “Turn Therapeutics” refer to Turn Therapeutics Inc. Overview Turn Therapeutics is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Our lead program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema. We intend to conduct an interim assessment at approximately 50% trial completion.

Financial trend for Turn Therapeutics Inc. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) went from -$1.77 million (2024-12-31) to -$3.19 million (2025-12-31), a change of -80.6%; total assets went from $2.05 million (2024-12-31) to $12.16 million (2025-12-31), a change of +493.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2023016, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Turn Therapeutics Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Turn Therapeutics Inc. (CIK 2023016) lists its business address as 250 NORTH WESTLAKE BLVD., WESTLAKE VILLAGE, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 27 8-K or 6-K reports in Turn Therapeutics Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-18 to 2026-10-07, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2023016 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2024-05-22. Insider trades for Turn Therapeutics Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ucloudlink ucloudlink group inc. ucloudlink.com

Also searched as: "ucloudlink" | "ucloudlink group inc." | "ucloudlink.com"

This section ties “Ucloudlink ucloudlink group inc. ucloudlink.com” to uCloudlink Group Inc. (ticker UCL), SEC Central Index Key 1775898, an EDGAR registrant classified as “Communications Services, NEC” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-10-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-03-27 by uCloudlink Group Inc. (CIK 1775898) — source document:

We commenced our operations by establishing Shenzhen uCloudlink Network Technology Co., Ltd. in August 2014 and Beijing uCloudlink New Technology Co., Ltd. three months later. Our holding company, UCLOUDLINK GROUP INC., was incorporated in August 2014 in the Cayman Islands to facilitate financing and offshore listing. In September 2014, our holding company established a wholly-owned subsidiary in Hong Kong, UCLOUDLINK (HK) LIMITED, which is a subsidiary of HONG KONG UCLOUDLINK NETWORK TECHNOLOGY LIMITED, an entity through which we conduct our business operations in Hong Kong. In February 2021, we established a new subsidiary in the U.K. named UCLOUDLINK UK LIMITED to facilitate our expansion in the U.K. market and improve the efficiency of local management.

Financial trend for uCloudlink Group Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $71.46 million (2022-12-31) to $81.45 million (2025-12-31), a change of +14.0%; net income (loss) went from -$19.85 million (2022-12-31) to $6.30 million (2025-12-31), a change of +131.7%; total assets went from $45.93 million (2022-12-31) to $67.83 million (2025-12-31), a change of +47.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1775898, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures uCloudlink Group Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for uCloudlink Group Inc. (CIK 1775898) lists its business address as UNIT 2214-RM1, 22/F, MIRA PLACE TOWER A, HONG KONG, which helps confirm you are on the right company’s site.

Current reports. Of the 60 8-K or 6-K reports in uCloudlink Group Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-13 to 2026-08-18, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1775898 is on the EDGAR company page; the latest 20-F there is dated 2026-03-27 and the oldest filing in the recent index dates from 2019-05-24. Insider trades for uCloudlink Group Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Venhub global venhub global inc. venhub.com

Also searched as: "venhub global" | "venhub global inc." | "venhub.com"

This section ties “Venhub global venhub global inc. venhub.com” to VenHub Global, Inc. (ticker VHUB), SEC Central Index Key 1972234, an EDGAR registrant classified as “Misc Industrial & Commercial Machinery & Equipment” and organised in DE, formerly known as Autonomous Solutions, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-19, and this view starts from filings dated on or before 2026-09-03. Nothing here is a recommendation to trade the security.

Financial trend for VenHub Global, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $295,357 (2025-09-30) to $86,614 (2026-06-30), a change of -70.7%; net income (loss) went from -$19.35 million (2025-09-30) to -$10.49 million (2026-06-30), a change of +45.8%; total assets went from $4.61 million (2025-09-30) to $8.12 million (2026-06-30), a change of +76.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1972234, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures VenHub Global, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for VenHub Global, Inc. (CIK 1972234) lists its business address as 5360 PROCYON ST, LAS VEGAS, NV, which helps confirm you are on the right company’s site.

Current reports. Of the 8 8-K or 6-K reports in VenHub Global, Inc.’s recent EDGAR index, the 4 listed here run from 2026-02-12 to 2026-05-21, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 60 recent EDGAR filings, VenHub Global, Inc. most often filed 8-K (8), 4 (5), POS AM (5), C/A (5). A selection from 2026-09-03 to 2026-09-14:

The full record for CIK 1972234 is on the EDGAR company page; the latest 10-K there is dated 2026-03-24 and the oldest filing in the recent index dates from 2023-04-13. One example from this record is the 4 filed 2026-10-13 (document). Insider trades for VenHub Global, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Vivani medical vivani medical inc. vivani.com

Also searched as: "vivani medical" | "vivani medical inc." | "vivani.com"

This section ties “Vivani medical vivani medical inc. vivani.com” to Vivani Medical, Inc. (ticker VANI), SEC Central Index Key 1266806, an EDGAR registrant classified as “Electromedical & Electrotherapeutic Apparatus” and organised in DE, formerly known as SECOND SIGHT MEDICAL PRODUCTS INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-19. Nothing here is a recommendation to trade the security.

Financial trend for Vivani Medical, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$13.89 million (2022-12-31) to -$26.61 million (2025-12-31), a change of -91.6%; total assets went from $51.13 million (2022-12-31) to $39.39 million (2025-12-31), a change of -23.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1266806, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Vivani Medical, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Vivani Medical, Inc. (CIK 1266806) lists its business address as 1350 S. LOOP ROAD, ALAMEDA, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 232 8-K or 6-K reports in Vivani Medical, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-06 to 2026-09-16, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 836 recent EDGAR filings, Vivani Medical, Inc. most often filed 4 (336), 8-K (232), 10-Q (35), 3 (35). A selection from 2026-07-30 to 2026-10-19:

The full record for CIK 1266806 is on the EDGAR company page; the latest 10-K there is dated 2026-03-26 and the oldest filing in the recent index dates from 2003-10-10. Insider trades for Vivani Medical, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Wimi hologram cloud wimi hologram cloud inc. wimiar.com

Also searched as: "wimi hologram cloud" | "wimi hologram cloud inc." | "wimiar.com"

This section ties “Wimi hologram cloud wimi hologram cloud inc. wimiar.com” to WiMi Hologram Cloud Inc. (ticker WIMI), SEC Central Index Key 1770088, an EDGAR registrant classified as “Services-Prepackaged Software” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-09-17, and this view starts from filings dated on or before 2026-04-03. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-24 by WiMi Hologram Cloud Inc. (CIK 1770088) (passage 2, continuing from the earlier excerpt) — source document:

ADDITIONAL INFORMATION 96 A. Share Capital 96 B. Memorandum and Articles of Association 96 C. Material Contracts 97 D. Exchange Controls 97 E. Taxation 97 F. Dividends and Paying Agents 102 G. Statement By Experts 102 H. Documents on Display 102 I. Subsidiary Information 103 ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 103 ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 104 ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 105 ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 105 ITEM 15. CONTROLS AND PROCEDURES 106 ITEM 16. [RESERVED] 107 ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 107 ITEM 16B. CODE OF ETHICS 107 ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 108 ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 108 ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 108 ITEM 16F. CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT 108 ITEM 16G. CORPORATE GOVERNANCE 108 ITEM 16H. MINE SAFETY DISCLOSURE 109 ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 109 ITEM 16J. INSIDER TRADING POLICIES 109 ITEM 16K. CYBERSECURITY 109 ITEM 17.

Financial trend for WiMi Hologram Cloud Inc. from annual reports, periods 2018-12-31 to 2021-12-31: revenue went from 225,271,564 CNY (2018-12-31) to 933,791,519 CNY (2021-12-31), a change of +314.5%; net income (loss) went from 89,217,792 CNY (2018-12-31) to -235,973,179 CNY (2021-12-31), a change of -364.5%; total assets went from 607,483,426 CNY (2018-12-31) to 1,505,028,697 CNY (2021-12-31), a change of +147.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1770088, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures WiMi Hologram Cloud Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for WiMi Hologram Cloud Inc. (CIK 1770088) lists its business address as NO. 6 XIAOZHUANG, BEIJING, which helps confirm you are on the right company’s site.

Current reports. Of the 54 8-K or 6-K reports in WiMi Hologram Cloud Inc.’s recent EDGAR index, the 4 listed here run from 2025-04-30 to 2025-09-26, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1770088 is on the EDGAR company page; the latest 20-F there is dated 2026-04-24 and the oldest filing in the recent index dates from 2019-03-15. One example from this record is the 3 filed 2026-05-08 (document). Insider trades for WiMi Hologram Cloud Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Work medical technology work medical technology group hzsy120.com

Also searched as: "work medical technology" | "work medical technology group" | "hzsy120.com"

This section ties “Work medical technology work medical technology group hzsy120.com” to WORK Medical Technology Group LTD (ticker WOK), SEC Central Index Key 1929783, an EDGAR registrant classified as “Surgical & Medical Instruments & Apparatus” and organised in China, formerly known as WORK Medical Technology Group LTD. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-08-24. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-01-30 by WORK Medical Technology Group LTD (CIK 1929783) — source document:

Work BVI is our wholly-owned subsidiary formed in the British Virgin Islands on March 15, 2022. Work Medical Technology is Work BVI’s wholly-owned subsidiary formed in Hong Kong on April 19, 2022. WFOE, is Work Medical Technology’s wholly-owned subsidiary formed in Hangzhou on April 28, 2022. Work Hangzhou is WFOE’s wholly-owned subsidiary formed in Hangzhou on November 10, 2021. In addition, on September 2, 2025, the Company formed a new subsidiary in Hong Kong, Work RWA TECH LIMITED, which is a wholly owned subsidiary of Work Medical Technology. 54 Our operations are primarily conducted by Work Hangzhou and its subsidiaries in China. Work Hangzhou is a limited liability company formed in China on November 10, 2021 with registered capital of RMB100 million.

Financial trend for WORK Medical Technology Group LTD from annual reports, periods 2022-09-30 to 2025-09-30: revenue went from $19.71 million (2022-09-30) to $9.85 million (2025-09-30), a change of -50.0%; net income (loss) went from $865,210 (2022-09-30) to -$1.07 million (2025-09-30), a change of -224.0%; total assets went from $29.96 million (2023-09-30) to $33.16 million (2025-09-30), a change of +10.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1929783, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerIncludingAssessedTax; 4 periods shown, dashes mark figures WORK Medical Technology Group LTD did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for WORK Medical Technology Group LTD (CIK 1929783) lists its business address as 1/88 COOK ST, AUCKLAND CITY, which helps confirm you are on the right company’s site.

Current reports. Of the 30 8-K or 6-K reports in WORK Medical Technology Group LTD’s recent EDGAR index, the 4 listed here run from 2026-06-05 to 2026-08-24, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1929783 is on the EDGAR company page; the latest 20-F there is dated 2026-01-30 and the oldest filing in the recent index dates from 2022-06-23. Insider trades for WORK Medical Technology Group LTD appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Yxt.com yxt.com group yxt.com group holding yxt.com group holding limited

Also searched as: "yxt.com" | "yxt.com group" | "yxt.com group holding" | "yxt.com group holding limited"

This section ties “Yxt.com yxt.com group yxt.com group holding yxt.com group holding limited” to YXT.COM GROUP HOLDING Ltd (ticker YXT), SEC Central Index Key 1872090, an EDGAR registrant classified as “Services-Prepackaged Software” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-08-17. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-29 by YXT.COM GROUP HOLDING Ltd (CIK 1872090) — source document:

MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 117 ​ ITEM 8. FINANCIAL INFORMATION 119 ​ ITEM 9. THE OFFER AND LISTING 121 ​ ITEM 10. ADDITIONAL INFORMATION 121 ​ ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 137 ​ ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 137 PART II 140 ​ ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 140 ​ ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 140 ​ ITEM 15. CONTROLS AND PROCEDURES 140 ​ ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 142 ​ ITEM 16B. CODE OF ETHICS 142 ​ ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 143 ​ ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 143 ​ ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 144 ​ ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT 144 ​ ITEM 16G. CORPORATE GOVERNANCE 145 ​ ITEM 16H. MINE SAFETY DISCLOSURE 145 ​ ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 145 ​ ITEM 16J. INSIDER TRADING POLICIES 145 ​ ITEM 16K. CYBERSECURITY 146 PART III ​ 147 ​ ITEM 17.

Financial trend for YXT.COM GROUP HOLDING Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 430,636,000 CNY (2022-12-31) to 331,190,000 CNY (2024-12-31), a change of -23.1%; net income (loss) went from -614,775,000 CNY (2022-12-31) to -158,932,000 CNY (2025-12-31), a change of +74.1%; total assets went from 924,846,000 CNY (2023-12-31) to 507,049,000 CNY (2025-12-31), a change of -45.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1872090, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures YXT.COM GROUP HOLDING Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for YXT.COM GROUP HOLDING Ltd (CIK 1872090) lists its business address as FLOOR 20, BUILDING 2, NO. 209,, JIANGSU, 215011, which helps confirm you are on the right company’s site.

Current reports. Of the 18 8-K or 6-K reports in YXT.COM GROUP HOLDING Ltd’s recent EDGAR index, the 4 listed here run from 2026-07-31 to 2026-08-17, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1872090 is on the EDGAR company page; the latest 20-F there is dated 2026-04-29 and the oldest filing in the recent index dates from 2021-07-16. Insider trades for YXT.COM GROUP HOLDING Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Flagstar bank

Also searched as: -site:facebook.com -site:fb.me -site:youtube.com -site:youtu.be -site:youtube.be -site:twitter.com -site:instagram.com -site:tiktok.com -site:vm.tiktok.com -site:t.co -site:x.com -site:reddit.com "flagstar bank"

This section ties “Flagstar bank” to FLAGSTAR BANK, NATIONAL ASSOCIATION (ticker FLG, FLG-PA, FLG-PU), SEC Central Index Key 910073, an EDGAR registrant classified as “Savings Institutions, Not Federally Chartered” and organised in an unstated jurisdiction, formerly known as FLAGSTAR FINANCIAL, INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-23. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-27 by FLAGSTAR BANK, NATIONAL ASSOCIATION (CIK 910073) — source document:

Where we say "we," "us," "our," the "Bank," the "Company," or "Flagstar," in this report we usually mean Flagstar Bank, National Association. Flagstar Bank, National Association, is a national banking association headquartered in Hicksville, New York which had $87.5 billion of assets, $61.0 billion of loans, deposits of $66.0 billion, and total stockholders’ equity of $8.1 billion as of December 31, 2025. The Bank went public in 1993 and has grown organically and through a series of accretive mergers and acquisitions. We operate in a single reportable segment and have identified one reporting unit which is the same as our operating segment. We continue to assess our reportable segments and reporting units, which may result in a change to either or both in future reporting periods.

Financial trend for FLAGSTAR BANK, NATIONAL ASSOCIATION from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $650.00 million (2022-12-31) to -$177.00 million (2025-12-31), a change of -127.2%; total assets went from $90.14 billion (2022-12-31) to $87.51 billion (2025-12-31), a change of -2.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 910073, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures FLAGSTAR BANK, NATIONAL ASSOCIATION did not tag for that period.

FLAGSTAR BANK, NATIONAL ASSOCIATION has 1000 filings in its recent EDGAR index, including 10 annual reports and 32 quarterly reports; its newest filing is a 8-K from 2026-10-23.

Current reports. Of the 189 8-K or 6-K reports in FLAGSTAR BANK, NATIONAL ASSOCIATION’s recent EDGAR index, the 4 listed here run from 2026-05-18 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 910073 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2016-04-22. Insider trades for FLAGSTAR BANK, NATIONAL ASSOCIATION appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET